Beth Ashbridge

Beth Ashbridge Ph.D.

Beth Ashbridge Ph.D.
+44 (0) 20 7667 3470

Beth Ashbridge is a senior associate in Goodwin’s Technology and Life Sciences group. Her practice focuses on commercialization of intellectual property rights, particularly in the life sciences and technology sectors. Goodwin’s Technology and Life Sciences group advises on transactions, including licenses, collaborations, distribution, manufacturing, outsourcing and R&D projects, as well as regulatory matters, contract and patent disputes, fundraisings, M&A transactions, and IPOs.

Beth joined Goodwin in 2013 as a Science Advisor and later qualified as a JD from the part-time evening program at Fordham University School of Law with honors (cum laude), and was extended the Paul Fuller Scholar Designation. Beth has been involved in several Hatch-Waxman and BPCIA patent litigation cases on both the brand and generic side and has contributed to the firm’s work in patent opinions and due diligence. Beth is an active contributor to the firm’s biosimilars blog, Big Molecule Watch, which is dedicated to providing resources and observations through Goodwin’s active watch of the world of biologics, biosimilars and the Biologics Price Competition and Innovation Act (BPCIA). Beth is an editor of Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., which provides expert guidance and practical know-how for lawyers working in this burgeoning area of the law. Beth is also a member of the firm’s specialist sectors: Late Stage Drug Development, FDA Litigation, and Life Science Disputes.

Beth brings to her practice an exceptional combination of patent law expertise and technical proficiency in the pharmaceutical and biotechnology fields. Prior to joining Goodwin, Beth carried out her graduate research in the Chemical Biology program at the Department of Chemistry, University of Cambridge, under the supervision of Sir Professor Shankar Balasubramanian FRS FMedSci and later worked as a post-doctoral Research Fellow in the Cell Biology Program at Memorial Sloan-Kettering Cancer Center in New York City under the guidance of Dr. Malcolm A.S. Moore.




Fordham University School of Law

(cum laude; Paul Fuller Scholar; Activities: Urban Law Journal)


University of Cambridge


Durham University



  • New York
  • England & Wales